J&J seeks to boost stent with DTC ads

Share this article:
With Abbott and Medtronic crowding into a market it has long split with Boston Scientific, Johnson & Johnson's Cordis is looking to raise the profile of its Cypher stent with a consumer advertising campaign—a possible first for the category.

In October, the company launched newspaper ads in The New York Times, The Wall Street Journal and USA Today.

The ads, by BBDO, show an actual-size image of the stent under headlines reading “Tennis partner,” “Hiking gear” and “Gym Equipment.”

Copy advises angina sufferers that a Cypher stent “can help get your blood pumping and your body moving once again. So you can get back to living life—playing tennis, running, working out, even sexual activity—without chest pains.”

“The goal is to help facilitate discussion between patients and physicians about coronary artery disease, the treatment options and of course, Cypher as well,” said Carol Goodrich, director of corporate comms for Cordis.

The firm is employing search engine optimization methods to boost its rankings in Yahoo and WebMD searches.

New journal ads, created by BBDO's Omnicom sibling Harrison + Star, will debut soon.
Edelman is handling PR for the effort, while interactive is being handled in-house by Johnson & Johnson's global advertising department.

Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Read the complete April 2014 Digital Edition

Read the complete April 2014 Digital Edition

Click the above link to access the complete Digital Edition of the April 2014 issue of MM&M, with all text, charts and pictures.

Antidote: Are e-cigarettes safe?

Antidote: Are e-cigarettes safe?

The pros and cons of e-cigarettes

Combating concept churn

Combating concept churn

There's no cure. But the good news is that prophylaxis is possible.